Analysis of viral amino acids sequences and the IL28B SNP influencing the development of hepatocellular carcinoma in chronic hepatitis C

被引:29
|
作者
Miura, Mika [1 ]
Maekawa, Shinya [1 ]
Kadokura, Makoto [1 ]
Sueki, Ryota [1 ]
Komase, Kazuki [1 ]
Shindo, Hiroko [1 ]
Ohmori, Takako [1 ]
Kanayama, Asuka [1 ]
Shindo, Kuniaki [1 ]
Amemiya, Fumitake [1 ]
Nakayama, Yasuhiro [1 ]
Kitamura, Takatoshi [1 ]
Uetake, Tomoyoshi [1 ]
Inoue, Taisuke [1 ]
Sakamoto, Minoru [1 ]
Okada, Shunichi [1 ]
Enomoto, Nobuyuki [1 ]
机构
[1] Univ Yamanashi, Fac Med, Dept Internal Med 1, Chuo Ku, Yamanashi 4093898, Japan
关键词
HCV; HCC; Core; IL28B; VIRUS GENOTYPE 1B; CORE PROTEIN; COMBINATION THERAPY; IMPORTANT PREDICTOR; RIBAVIRIN THERAPY; GENETIC-VARIATION; OXIDATIVE STRESS; LIVER-DISEASE; INTERFERON; REGION;
D O I
10.1007/s12072-011-9307-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims The association between hepatitis C virus (HCV) sequences with interleukin 28B (IL28B) single-nucleotide polymorphism (SNP) in the development of hepatocellular carcinoma (HCC) has not been well clarified. Methods Complete HCV open-reading frame sequences were determined in 20 patients developing HCC and 23 non-HCC patients with HCV-1b infection in two distant time points. An additional 230 patients were studied cross-sectionally for core and NS5A sequences with HCC development. Among them, 98 patients with available samples were investigated for changes in viral core sequences over time. Finally, IL28B SNPs and HCC development were investigated in 228 patients. Results During observation period (HCC for 10.8 years, and non-HCC for 11.1 years), changes in core a. a. 70 and three amino acid positions in NS5A were characteristics of the patients developing HCC. In 230 patients, Q (glutamine) or H (histidine) to R (arginine) ratio at core a. a. 70 was significantly higher in the HCC group (HCC group 43: 22 vs. non-HCC group 66: 99, p = 0.001). A change in core R70Q was observed over time in 11 patients associated with a decrease in platelets (p = 0.005) and albumin (p = 0.005), while a Q70R change was observed in 4 patients without associated changes in platelets (nonsignificant) and albumin (nonsignificant). IL28B SNP showed significant correlation with the core a. a. 70 residue. There was no evident link between IL28B SNPs and the occurrence of HCC. Conclusions Hepatitis C virus core a. a. 70 residue is associated with liver disease progression and is independent factor for HCC development in genotype-1b infection. IL28B SNPs are related to core a. a. 70 residue, but not to HCC. The functional relevance of core a. a. 70 residue in hepatitis C pathogenesis should be further investigated.
引用
收藏
页码:386 / 396
页数:11
相关论文
共 50 条
  • [1] Analysis of viral amino acids sequences and the IL28B SNP influencing the development of hepatocellular carcinoma in chronic hepatitis C
    Mika Miura
    Shinya Maekawa
    Makoto Kadokura
    Ryota Sueki
    Kazuki Komase
    Hiroko Shindo
    Takako Ohmori
    Asuka Kanayama
    Kuniaki Shindo
    Fumitake Amemiya
    Yasuhiro Nakayama
    Takatoshi Kitamura
    Tomoyoshi Uetake
    Taisuke Inoue
    Minoru Sakamoto
    Shunichi Okada
    Nobuyuki Enomoto
    Hepatology International, 2012, 6 : 386 - 396
  • [2] IL28B POLYMORPHISM IS NOT ASSOCIATED WITH DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C IN JAPAN
    Nakamoto, Shingo
    Imazeki, Fumio
    Kanda, Tatsuo
    Wu, Shuang
    Miyamura, Tatsuo
    Tawada, Akinobu
    Arai, Makoto
    Fujiwara, Keiichi
    Saito, Kengo
    Shirasawa, Hiroshi
    Yokosuka, Osamu
    HEPATOLOGY, 2011, 54 : 1183A - 1184A
  • [3] IL28B polymorphisms and chronic hepatitis C
    Chevaliez, S.
    Hezode, C.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2010, 34 (11): : 587 - 589
  • [4] Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection
    Joshita, Satoru
    Umemura, Takeji
    Katsuyama, Yoshihiko
    Ichikawa, Yuki
    Kimura, Takefumi
    Morita, Susumu
    Kamijo, Atsushi
    Komatsu, Michiharu
    Ichijo, Tetsuya
    Matsumoto, Akihiro
    Yoshizawa, Kaname
    Kamijo, Nozomi
    Ota, Masao
    Tanaka, Eiji
    HUMAN IMMUNOLOGY, 2012, 73 (03) : 298 - 300
  • [5] ASSOCIATION BETWEEN IL28B GENE VARIATION AND DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AFTER INTERFERON THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C
    Asahina, Y.
    Tanaka, K.
    Suzuki, Y.
    Tamaki, N.
    Hoshioka, T.
    Kato, T.
    Yasui, Y.
    Hosokawa, T.
    Ueda, K.
    Kuzuya, T.
    Tsuchiya, K.
    Nakanishi, H.
    Itakura, J.
    Takahashi, Y.
    Kurosaki, M.
    Izumi, N.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S37 - S37
  • [6] Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma
    Shan Ren
    Junfeng Lu
    Xiaofei Du
    Yanxiang Huang
    Lina Ma
    Honglei Huo
    Xinyue Chen
    Lai Wei
    Cancer Immunology, Immunotherapy, 2012, 61 : 1433 - 1439
  • [7] Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma
    Ren, Shan
    Lu, Junfeng
    Du, Xiaofei
    Huang, Yanxiang
    Ma, Lina
    Huo, Honglei
    Chen, Xinyue
    Wei, Lai
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (09) : 1433 - 1439
  • [8] Relationship of IL28B gene polymorphism with liver cirrhosis and hepatocellular carcinoma of chronic hepatitis C patients in Korea
    Jung, Young Kul
    Jeong, Seok Hu
    Choi, Duck Joo
    Kim, Yun Soo
    Kwon, Oh Sang
    Kim, Jung Ho
    Lee, Jong Joon
    Lee, Ji Won
    Ha, Minsu
    Kim, Ju Seung
    Ahn, Hong Dae
    Park, Jaechan
    Lee, Jung Hyun
    Kim, Ju Hyun
    HEPATOLOGY, 2012, 56 : 665A - 665A
  • [9] IL28B and antiviral therapy of chronic viral hepatitis: what remains?
    Grammatikos, G.
    Sarrazin, C.
    GASTROENTEROLOGE, 2013, 8 (04): : 322 - 329
  • [10] Investigation of the Relationship Between IL28B Polymorphisms and Plasma IL28B Levels in Patients with Chronic Hepatitis B or C
    Kuralay, Zeynep Koc
    Tug, Esra
    Fidan, Isil
    MIKROBIYOLOJI BULTENI, 2021, 55 (03): : 374 - 388